Sucheingabe:

A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z

KürzelTestEinh.NormalbereichHinweis
P53P53-AKU/ml<120.0MATERIAL: Serum/Vollblut
M6GP-AK: Alternaria alternata IgGmg/l0.000-39.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M3GP-AK: Aspergillus fumigatus IgGmg/l0.000-39.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M12GP-AK: Aureobasidium pullulansmg/l0.000-22.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M5GP-AK: Candida albicans IgGmg/l0.000-39.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M32GP-AK: Cladosporium clad. IgG-AKmg/l0.000-30.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M2GPP-AK: Cladosporium herbarum IgGmg/l0.000-39.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
E86GP-AK: Entenfedern IgG-AKmg/l0.000-10.000MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK
M9GP-AK: Fusarium prolifer. IgG-AKmg/l0.000-15.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
E70GP-AK: Gänsefedern IgG-AKmg/l0.000-10.000MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK
E85GP-AK: Hühnerfedern IgG-AKmg/l0.000-14.000MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK
K77GP-AK: Isozyanat HDI IgG-AKmg/l-MATERIAL: Serum, METHODE: FEIA
K76GP-AK: Isozyanat MDI IgG-AKmg/l-MATERIAL: Serum, METHODE: FEIA
K75GP-AK: Isozyanat TDI IgG-AKmg/l-MATERIAL: Serum, METHODE: FEIA
GM42P-AK: Laceyella saccarimg/l0.000-21.500MATERIAL: Serum, METHODE: ELISA
GM22P-AK: Micropolyspora faenimg/l0.000-10.000MATERIAL: Serum, METHODE: ELISA
M4GP-AK: Mucor racemosus IgGmg/l0.000-39.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
GE92P-AK: Papagei-Serum,Feder,Kotmg/l0.000-10.000MATERIAL: Serum, METHODE: ELISA,
M209GP-AK: Penicillium glab. IgG-AKmg/l0.000-21.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M1GP-AK: Penicillium notatum IgGmg/l0.000-27.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
E3GP-AK: Pferdeschuppen IgG-AKmg/l0.000-15.000MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK
M11GP-AK: Rhizopus nigricansmg/l0.000-8.000MATERIAL: Serum, METHODE: ELISA
GM24P-AK: Stachybotrys atramg/l0.000-10.000MATERIAL: Serum, METHODE: ELISA
GE93P-AK: Taubenserummg/l0.000-10.000MATERIAL: Serum, METHODE: ELISA,
GE91P-AK: Tauben-Serum,Feder,Kotmg/l0.000-10.000MATERIAL: Serum, METHODE: ELISA,
ZM51P-AK: Thermopolyspora polysp.mg/l0.000-30.000MATERIAL: Serum, METHODE: ELISA
E78GP-AK: Wellensittichfeder IgG-AKmg/l<8.000MATERIAL: Serum, METHODE: FEIA
E77GPP-AK: Wellensittichkot IgG-AKmg/l<9.000MATERIAL: Serum, METHODE: FEIA
GE90P-AK: Wellensittichprot. IgG-AKmg/l<11.000MATERIAL: Serum, METHODE: FEIA
PDPalladium im Serumug/l0.00-0.20MATERIAL: Serum/Vollblut, METHODE: AAS
PANCAP-ANCA (anti-MPO)U/ml0.00-20.00MATERIAL: Serum/Vollblut, METHODE: CLIA
AMYLPANKPankreasamylaseU/l13.0-53.0MATERIAL: Serum, METHODE: photometrisch
B5UPantothensäure i.Harn-MATERIAL: 24h-Sammelharn, METHODE: HPLC
PAPPAP Abstrich-MATERIAL: Abstrich; Methode: cytologisch
PAPP-APAPP-A-MATERIAL: Serum/Vollblut, METHODE: TRACE
PARACETParacetamolmg/l5.00-25.00MATERIAL: Serum/Vollblut METHODE: GC-MS
PARA1Parainfluenza 1Titer0.0-40.0MATERIAL: Serum/Vollblut, METHODE: KBR
PARA2Parainfluenza 2Titer0.0-40.0MATERIAL: Serum/Vollblut, METHODE: KBR
PARA3Parainfluenza 3Titer0.0-40.0MATERIAL: Serum/Vollblut, METHODE: KBR
PARAAGParainfluenza Antigennachweis-MATERIAL: Nasensekret
PARATParathormonng/l10.0-70.0MATERIAL: Serum/Vollblut, METHODE: LIA
PARATRELPParathormon related Proteinpmol/l0.00-1.40MATERIAL: EDTA-Plasma gefroren, METHODE: RIA
PARIETAParietalzell-AKU/ml0.00-9.90MATERIAL: Serum/Vollblut METHODE: ELISA
AMYLPAROTParotisamylaseU/l18.0-65.0MATERIAL: Serum, METHODE: Isoenzymelphor
PAROXETINParoxetinng/ml20.0-65.0MATERIAL: Serum/Vollblut, METHODE: LC-MS/MS
PARVOAVIDParvovirus B19 Avidität-MATERIAL: Serum/Vollblut
PARVOAGParvovirus B19 DNA-MATERIAL: EDTA-Blut; METHODE: PCR
PARVOPCRParvovirus B19 DNA (PCR)-MATERIAL: Serum/Sputum/Punktat, METHODE: PCR
PARVOGParvovirus B19 IgG-MATERIAL: Serum/Vollblut, METHODE: ELISA
PARVOQUANTParvovirus B19 IgG TiterU/ml-MATERIAL: Serum/Vollblut, METHODE: ELISA
PARVOMParvovirus B19 IgM-MATERIAL: Serum/Vollblut, METHODE: ELISA
PCNAPCNA-MATERIAL: Serum/Vollblut, METHODE: Immunoblot
PEMPHAKPemphigus-Ak-
PCPPentachlorphenolug/l<12.000MATERIAL: Serum (5 ml), METHODE: GC-MS
PEPSINOGENPepsinogenug/l-MATERIAL: Serum, METHODE: EIA
PERAMPPerampanelug/l180.00-980.00MATERIAL: Serum, METHODE: LC-MS
PERTAPertussis IgA-MATERIAL: Serum/Vollblut, METHODE: IFT
PERTGPertussis IgG-MATERIAL: Serum/Vollblut, METHODE: ELISA
PERTGQUANTPertussis IgG Impftiter-MATERIAL: Serum/Vollblut, METHODE: ELISA
PERTMPertussis IgM-MATERIAL: Serum/Vollblut, METHODE: ELISA
PHENCYSPhencyclidin (S)ng/ml0.0-20.0MATERIAL: Serum, METHODE: FPIA
PHENCYHPhencyclidin (U)ng/ml0.0-25.0MATERIAL: Spontanharn, METHODE: FPIA
PHENOPhenobarbitalug/ml14.90-40.10MATERIAL: Serum/Vollblut, METHODE: FPIA
PGAKREAUPhenylglyoxylsäure/K i.Harnmg/g Krea-MATERIAL: Spontanharn,Methode: HPLC
PGAUPhenylglyoxylsäure i.Harnmg/l-MATERIAL: Spontanharn, METHODE: HPLC
PHENYPhenytoinug/ml10.00-20.00MATERIAL: Serum/Vollblut, METHODE: FPIA
PCLEARPhosphat - Clearanceml/min5.40-16.20MATERIAL: Serum/Vollblut+24h-Sammelharn
PLA2RAKPhospholipase-A2-Rezeptor AKRE/ml<14.0MATERIAL: Serum; Methode: ELISA
APLAKPhospholipid AK-MATERIAL: Serum/Vollblut
APLAKGPhospholipid Screen IgGU/ml0.00-7.00MATERIAL: Serum, METHODE: ELISA
APLAKMPhospholipid Screen IgMU/ml0.00-7.00MATERIAL: Serum, METHODE: ELISA
PPhosphormmol/l0.740-1.520MATERIAL: Serum/Vollblut, METHODE: photometrisch
PHPhosphor im 24h-Harnmmol/24h13.000-42.000MATERIAL: 24h-Sammelharn, METHODE: photometrisch
PHKATPH-Wert (Sammelharn)2.0-3.0MATERIAL: 24h-Sammelharn angesäuert, METHODE:ph-metr.
PHWHPH-Wert (U)5.00-7.00MATERIAL: Spontanharn, METHODE: STIX
PHYTSREPhytansäureumol/l<10.00MATERIAL: Serum Methode: GC-MS
PHYTANSREPhytansäuremg/l<5.00MATERIAL: Serum Methode: GC-MS
PINPPINP Prokollagen I N Propeptidug/l-MATERIAL: Serum METHODE: ECLIA
PLAPPLAP (ELISA)mU/l0.0-100.0MATERIAL: Serum/Vollblut, METHODE: EIA
PLASsppAGPlasmodium spp AG (ICT)-MATERIAL: Serum/Vollblut, METHODE: ICT
PNEUQUANTPneumokokken IgG Impftitermg/l0.00-3.20MATERIAL: Serum/Vollblut, METHODE: EIA
PNEUPCRPneumokokken PCR-MATERIAL: Abstrich ; METHODE: PCR
POLIONEU1Polio Typ1 ImpftiterTiter-MATERIAL: Serum
PBGUPorphobilinogen i.Harnmg/l-MATERIAL: Spontanharn,24h-Sammelharn METHODE:Säulentrennung/photom.
PBGHPorphobilinogen im 24h-Harnmg/24h0.100-1.700MATERIAL: 24h-Sammelharn, METHODE: Säulentrennung/photom.
PORPHDIFFHPorphyrindifferenzierung-
PORPHGESPorphyrine i. Serumug/dl<2.000MATERIAL: Serum, METHODE: HPLC
PRAEALBPräalbuming/l0.200-0.400MATERIAL: Serum/Vollblut METHODE: Nephelometrisch
PRAEAKPräzipitierende IgG-Antikörper-MATERIAL: Serum/Vollblut, METHODE: ELISA
PREGABAPregabalinmg/l2.00-5.00MATERIAL: Serum/Vollblut METHODE: LC-MS/MS
PREGPregnandiolmg/24h0.00-9.50MATERIAL: 24h-Sammelharn angesäuert
PREGSULFPregnenolonsulfatug/l27.00-80.00MATERIAL: Serum/Vollblut,
PRIMPrimidonmg/l5.00-10.00MATERIAL: Serum/Vollblut, METHODE: FPIA
PRISTANSREPristansäureumol/l<3.000MATERIAL: Serum Methode: GC-MS
PRNTPRNT auf SARS-CoV-2-MATERIAL: Serum/Vollblut, METHODE: Neutralisationstest
PROCALCProcalcitoninug/l0.000-0.500MATERIAL: Serum; Methode: LIA
GSTATFProfil Gerinnungsstatus-
PROGProgesteronug/l0.000-14.500MATERIAL: Serum/Vollblut, METHODE: CMIA
PROINSProinsulin (intaktes)pmol/l0.000-10.000MATERIAL: Serum/Vollblut, METHODE:
PROLProlactinng/ml-MATERIAL: Serum/Vollblut, METHODE: CMIA
PROLPEGProlactin nach PEG-Fällungng/ml-MATERIAL: Serum/Vollblut, METHODE: CMIA
BZPProlong.oral.Glukosetoleranz-MATERIAL: Fluorid-Blut
PROPAFENONPropafenonmg/l0.400-1.600MATERIAL: Serum, METHODE: LC-MS
PROPOXYUPropoxyphen i.Harnug/l0.0-50.0MATERIAL: Spontanharn; Methode: LC-MS
PROTCProtein C-Aktivität (chromogen)%70.0-140.0MATERIAL: Citrat, METHODE: ELFA
PROTHProtein im 24h-Harng/24h0.020-0.150MATERIAL: 24h-Sammelharn, METHODE: turbidimetrisch
PROTUQProtein Kreatinin Ratiomg/g0.00-100.00
PROTSFProtein S (frei)%60.10-139.00MATERIAL: Citrat, METHODE: chromogenes Substrat
PROTHIPENProthipendylug/l5.00-20.00MATERIAL: Serum; METHODE: LC-MS
PSAFTUPSA-frei (Tumormarker)%>18.00MATERIAL: Serum/Vollblut, METHODE: CMIA
PSAPSA Screeningng/ml0.000-4.000MATERIAL: Serum/Vollblut, METHODE: CMIA
PSILOCYBHPsilocybin (U)ng/ml0.0-10.0MATERIAL: Spontanharn (10ml), METHODE: CEDIA
PTPT (Quick)%70.0-120.0MATERIAL: Citrat, METHODE: Clotting
PTMUTPT-Mutation 20210A-MATERIAL: EDTA; Methode: Gentest
PTTPTTsec23.0-40.0MATERIAL: Citrat, METHODE: Clotting
PYRUVATPyruvatumol/l39.00-82.00MATERIAL: Fluorid-Blut, METHODE: photometrisch